| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $901.4M | +15.5% |
| Cost of Revenue | $361.8M | +15.0% |
| Gross Profit | $539.6M | +15.8% |
| R&D Expense | $161.6M | +13.4% |
| SG&A Expense | $138.5M | -13.9% |
| Operating Income | $157.0M | +72.5% |
| Interest Expense | $9.2M | +1701.2% |
| Pre-tax Income | $206.7M | +111.5% |
| Income Tax | -$52.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $254.5M | -40.6% |
| Accounts Receivable | $90.9M | +25.4% |
| Current Assets | $427.0M | -21.2% |
| Total Assets | $1.84B | +12.1% |
| Current Liabilities | $619.5M | +180.4% |
| Long-term Debt | $1.30B | -12.8% |
| Total Liabilities | $1.87B | +1.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $309.6M | +9.5% |
| Capital Expenditures | $129.1M | -27.5% |
| Investing Cash Flow | -$268.3M | -183.0% |
| Financing Cash Flow | -$216.9M | -183.7% |
| Free Cash Flow | $180.5M | +72.6% |
| -498.3% |
| Net Income | $259.3M | +206.8% |
| EPS (Basic) | $2.83 | +207.6% |
| EPS (Diluted) | $2.52 | +183.1% |
| Stockholders' Equity |
| -$28.7M |
| +85.9% |